Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Plasmablastic Lymphoma × Bortezomib × Clear all

Sponsor

Conditions

Multiple Myeloma 152 Lymphoma, Mantle-Cell 30 Lymphoma, Non-Hodgkin 22 Lymphoma, Follicular 22 Lymphoma 22 Recurrence 21 Neoplasms, Plasma Cell 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia, Myeloid, Acute 12 Waldenstrom Macroglobulinemia 11 Lymphoma, Large B-Cell, Diffuse 11 Immunoglobulin Light-chain Amyloidosis 10 Neoplasms 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Lymphoma, B-Cell 7 Leukemia 6 Carcinoma, Non-Small-Cell Lung 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Brain Neoplasms 5 Amyloidosis 5 Lymphoma, Large-Cell, Immunoblastic 4 Hematologic Diseases 4 Congenital Abnormalities 4 Paraproteinemias 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Erythroblastic, Acute 3 Leukemia, B-Cell 3

Interventions

Etoposide 4 Vincristine 3 Rituximab 3 Prednisone 3 Doxorubicin 3 Cyclophosphamide 3 prednylidene 2 deltacortene 2 Cytarabine 2 varlilumab 1 merphos 1 ixazomib 1 carmustine, poliferprosan 20 drug combination 1 belantamab mafodotin 1 Vorinostat 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 Methotrexate 1 Melphalan 1 Immunoglobulin G 1 Hydrocortisone 1 Disulfides 1 Carmustine 1 CT-P10 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡